Monitoring anticoagulant therapy in neonates is critical due to their varying responses to medication. Common monitoring methods include:
- Activated Partial Thromboplastin Time (aPTT): Often used to monitor heparin therapy. - Anti-Xa Levels: Used to monitor LMWH therapy.
Frequent monitoring is essential to avoid complications such as bleeding or inadequate anticoagulation, which can lead to further thromboembolic events.
